Etoposide plus cisplatin chemotherapy improves the efficacy and safety of small cell lung cancer.

Abstract

With equivalent efficacy, EP regimen is safer than EL regimen in the treatment of SCLC, which suggests that etoposide plus platinum has better clinical application value for SCLC.